Recalcitrant tinea capitis in WHIM syndrome

Area of Science:

• Immunology
• Genetics
• Dermatology

Background:

• WHIM syndrome is a primary immunodeficiency characterized by warts, hypogammaglobulinaemia, infections, and myelokathexis (WHIM).
• It typically results from activating mutations in the CXCR4 gene, impacting immune cell function.
• Patients with WHIM syndrome often experience recurrent and severe infections.

Observation:

• A case study focused on a patient diagnosed with WHIM syndrome presenting with a persistent tinea capitis infection.
• The fungal infection proved resistant to multiple conventional systemic antifungal therapies over a decade.
• This highlights a potential link between WHIM syndrome and refractory dermatophyte infections.

Findings:

• The WHIM syndrome patient's decade-long tinea capitis infection was successfully treated with posaconazole.
• This suggests posaconazole may be an effective therapeutic option for similar refractory cases.
• The study links CXCR4 gene defects to increased susceptibility to dermatophyte infections.

Implications:

• WHIM syndrome's CXCR4 gene defects may predispose individuals to specific dermatophyte infections like tinea capitis.
• This case underscores the importance of considering underlying immunodeficiencies in patients with recalcitrant fungal infections.
• Posaconazole emerges as a potential treatment for severe fungal infections in WHIM syndrome patients, warranting further investigation.